Arachidonic acid-derived eicosanoids in rheumatoid arthritis: implications and future targets

Author： Kapoor Mohit   Kojima Fumiaki   Crofford Leslie J  

Publisher： Future Medicine

ISSN： 1746-0816

Source： Future Rheumatology, Vol.1, Iss.3, 2006-06, pp. : 323-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Umbilical cord-derived stromal cell therapy for rheumatoid arthritis: what does the future hold?

By Kouroupis Dimitrios   McGonagle Dennis   Jones Elena  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 4, 2013-08 ,pp. : 417-420

Future Medicine

Access to resources Recommend Favorite

Update on Targets of Biologic Therapies for Rheumatoid Arthritis

By  

Current Rheumatology Reviews, Vol. 4, Iss. 4, 2008-11 ,pp. : 246-253

Bentham Science Publishers

Access to resources Recommend Favorite

Defining Novel Targets for Intervention in Rheumatoid Arthritis: An Overview

By  

Current Rheumatology Reviews, Vol. 4, Iss. 4, 2008-11 ,pp. : 214-218

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid-based Vesicular Nanocargoes as Nanotherapeutic Targets for the Effective Management of Rheumatoid Arthritis

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 11, Iss. 1, 2016-04 ,pp. : 3-15

Bentham Science Publishers

Access to resources Recommend Favorite

Newborn infant characteristics and risk of future rheumatoid arthritis: a twin-control study

By Svendsen Anders   Kyvik Kirsten   Houen Gunnar   Nielsen Christian   Holst René   Skytthe Axel   Junker Peter  

Rheumatology International, Vol. 34, Iss. 4, 2014-04 ,pp. : 523-528

Springer Publishing Company

Access to resources Recommend Favorite